Sign in

CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company

Vistagen Therapeutics, Inc.

Sign in to watch
Ticker
VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NV
Entity type
operating
EIN
205093315
Phone
650-577-3600
Business address
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Former names
Excaliber Enterprises, Ltd.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Option exercise VP, CFO AND SECRETARY acquired 18,750 shares (option exercise)
  9. 4 Grant or award CHIEF MEDICAL OFFICER acquired 2,655 shares (grant or award)
  10. 4 Grant or award VP, CFO AND SECRETARY acquired 3,575 shares (grant or award)
  11. 4 Grant or award PRES./CHIEF SCIENTIFIC OFFICER acquired 3,623 shares (grant or award)
  12. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 3,623 shares (grant or award)
  13. 4 Open-market sale VP, CFO AND SECRETARY sold 30,000 shares at $3.13 ($93,750)
  14. 4 Gift PRES./CHIEF SCIENTIFIC OFFICER gave 740 shares (gift)
  15. 4 Open-market buy PRES./CHIEF SCIENTIFIC OFFICER bought 3,750 shares at $2.73 ($10,238)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award CHIEF MEDICAL OFFICER acquired 2,260 shares (grant or award)

Page 5 of 15 · 282 filings